Drybench Patent.

Patent and exclusivity dates from January to June 2030 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from January to June 2030 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2030 July to December 2030

Listed patent expiry (450)

3 Jan 2030 · NDA 022029 · MENTHOL; METHYL SALICYLATE
US 8,809,615, product patent
patent.txt lines 916, 918
Flags
product
Product numbers
001, 002
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 7,816,383, use patent
patent.txt line 2,062
Flags
use code U-1603
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 7,910,610, use patent
patent.txt line 2,063
Flags
use code U-1604
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,013,002, use patent
patent.txt line 2,065
Flags
use code U-1603
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,084,475, use patent
patent.txt line 2,066
Flags
use code U-1605
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,318,780, use patent
patent.txt line 2,067
Flags
use code U-1606
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,648,098, use patent
patent.txt line 2,072
Flags
use code U-1611
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,754,109, use patent
patent.txt line 2,074
Flags
use code U-1612
Product numbers
001
8 Jan 2030 · NDA 208470 · PRASTERONE
US 8,957,054, use patent
patent.txt line 8,669
Flags
use code U-1922
Product numbers
001
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,816,383, use patent
patent.txt lines 9,337, 9,380, 9,423
Flags
use code U-2042
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,816,383, use patent
patent.txt lines 9,338, 9,381, 9,424
Flags
use code U-2050
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,910,610, use patent
patent.txt lines 9,339, 9,382, 9,425
Flags
use code U-2048
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,910,610, use patent
patent.txt lines 9,340, 9,383, 9,426
Flags
use code U-2049
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,013,002, use patent
patent.txt lines 9,341, 9,384, 9,427
Flags
use code U-2047
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,013,002, use patent
patent.txt lines 9,342, 9,385, 9,428
Flags
use code U-2082
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,084,475, use patent
patent.txt lines 9,344, 9,386, 9,430
Flags
use code U-2054
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,084,475, use patent
patent.txt lines 9,343, 9,429
Flags
use code U-2052
Product numbers
001, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,084,475, use patent
patent.txt line 9,387
Flags
use code U-2268
Product numbers
002
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,318,780, use patent
patent.txt lines 9,345, 9,388, 9,431
Flags
use code U-2046
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,318,780, use patent
patent.txt lines 9,346, 9,389, 9,432
Flags
use code U-2081
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,648,098, use patent
patent.txt lines 9,365, 9,408, 9,451
Flags
use code U-2051
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,648,098, use patent
patent.txt lines 9,366, 9,409, 9,452
Flags
use code U-2052
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,754,109, use patent
patent.txt lines 9,367, 9,410, 9,453
Flags
use code U-2053
Product numbers
001, 002, 003
15 Jan 2030 · NDA 203756 · CABOZANTINIB S-MALATE
US 11,091,439, substance patent
patent.txt lines 4,141, 4,149
Flags
substance
Product numbers
001, 002
15 Jan 2030 · NDA 203756 · CABOZANTINIB S-MALATE
US 11,091,440, product patent
patent.txt lines 4,142, 4,150
Flags
product
Product numbers
001, 002
15 Jan 2030 · NDA 203756 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 4,143, 4,151
Flags
use code U-1617
Product numbers
001, 002
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,091,439, substance patent
patent.txt lines 9,179, 9,199, 9,219
Flags
substance
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,091,440, product patent
patent.txt lines 9,180, 9,200, 9,220
Flags
product
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,181, 9,201, 9,221
Flags
use code U-1220
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,182, 9,202, 9,222
Flags
use code U-1480
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,183, 9,203, 9,223
Flags
use code U-2488
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,184, 9,204, 9,224
Flags
use code U-3225
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,185, 9,205, 9,225
Flags
use code U-4131
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,186, 9,206, 9,226
Flags
use code U-4156
Product numbers
001, 002, 003
17 Jan 2030 · NDA 021527 · IPRATROPIUM BROMIDE
US 8,474,447, product patent
patent.txt line 620
Flags
product delist requested
Product numbers
001
17 Jan 2030 · NDA 217603 · LOTILANER
US 8,383,659, substance and product patent
patent.txt line 20,034
Flags
substance product
Product numbers
001
18 Jan 2030 · NDA 202293 · DAPAGLIFLOZIN
US 8,721,615, product patent
patent.txt lines 3,000, 3,038
Flags
product delist requested
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,253, 3,277
Flags
substance product use code U-1406
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,254, 3,278
Flags
substance product use code U-2031
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,255, 3,279
Flags
substance product use code U-2032
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,256, 3,280
Flags
substance product use code U-2296
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,258, 3,282
Flags
substance product use code U-1406
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,259, 3,283
Flags
substance product use code U-2031
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,260, 3,284
Flags
substance product use code U-2032
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,261, 3,285
Flags
substance product use code U-2296
Product numbers
001, 002
20 Jan 2030 · NDA 207695 · CRISABOROLE
US 8,168,614, use patent
patent.txt line 7,408
Flags
use code U-1932
Product numbers
001
20 Jan 2030 · NDA 217514 · DABRAFENIB MESYLATE
US 7,994,185, substance and product patent
patent.txt line 19,995
Flags
substance product
Product numbers
001
20 Jan 2030 · NDA 217514 · DABRAFENIB MESYLATE
US 8,415,345, substance and product patent
patent.txt line 19,997
Flags
substance product
Product numbers
001
21 Jan 2030 · NDA 201110 · PROGESTERONE
US 8,580,293, use patent
patent.txt line 2,324
Flags
use code U-2810
Product numbers
001
21 Jan 2030 · NDA 210923 · LUSUTROMBOPAG
US 8,530,668, substance and product patent
patent.txt line 12,407
Flags
substance product
Product numbers
001
23 Jan 2030 · NDA 205109 · FERRIC OXYHYDROXIDE
US 9,561,251, product and use patent
patent.txt line 5,236
Flags
product use code U-1468
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 10,174,017, substance and product and use patent
patent.txt line 8,392
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 10,654,844, substance and product and use patent
patent.txt line 8,395
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 11,028,081, use patent
patent.txt line 8,399
Flags
use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 11,618,748, use patent
patent.txt line 8,401
Flags
use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 10,174,017, substance and product and use patent
patent.txt line 8,407
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 10,654,844, substance and product and use patent
patent.txt line 8,410
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 11,028,081, use patent
patent.txt line 8,414
Flags
use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 11,618,748, use patent
patent.txt line 8,417
Flags
use code U-1524
Product numbers
001
31 Jan 2030 · NDA 022032 · OMEPRAZOLE
US 12,599,565, product patent
patent.txt line 932
Flags
product
Product numbers
001
2 Feb 2030 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 8,916,195, use patent
patent.txt line 2,210
Flags
use code U-1639
Product numbers
001
3 Feb 2030 · NDA 205435 · TEDIZOLID PHOSPHATE
US 10,065,947, product patent
patent.txt line 5,383
Flags
product
Product numbers
001
3 Feb 2030 · NDA 205435 · TEDIZOLID PHOSPHATE
US 10,442,829, substance patent
patent.txt line 5,384
Flags
substance
Product numbers
001
3 Feb 2030 · NDA 205435 · TEDIZOLID PHOSPHATE
US 9,624,250, substance and product and use patent
patent.txt line 5,388
Flags
substance product use code U-2507
Product numbers
001
3 Feb 2030 · NDA 205435 · TEDIZOLID PHOSPHATE
US 9,988,406, product patent
patent.txt line 5,389
Flags
product
Product numbers
001
3 Feb 2030 · NDA 205436 · TEDIZOLID PHOSPHATE
US 10,065,947, product patent
patent.txt line 5,390
Flags
product
Product numbers
001
3 Feb 2030 · NDA 205436 · TEDIZOLID PHOSPHATE
US 10,442,829, substance patent
patent.txt line 5,391
Flags
substance
Product numbers
001
3 Feb 2030 · NDA 205436 · TEDIZOLID PHOSPHATE
US 9,624,250, substance and product and use patent
patent.txt line 5,395
Flags
substance product use code U-2507
Product numbers
001
3 Feb 2030 · NDA 205436 · TEDIZOLID PHOSPHATE
US 9,988,406, product patent
patent.txt line 5,396
Flags
product
Product numbers
001
4 Feb 2030 · NDA 202331 · AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
US 9,169,238, product patent
patent.txt lines 3,066, 3,069
Flags
product
Product numbers
001, 002
8 Feb 2030 · NDA 022532 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 8,617,597, product patent
patent.txt line 2,056
Flags
product
Product numbers
001
8 Feb 2030 · NDA 022574 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 8,617,597, product patent
patent.txt line 2,108
Flags
product
Product numbers
001
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 12,171,738, use patent
patent.txt lines 2,647, 2,710
Flags
use code U-4105
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,399,446, use patent
patent.txt line 2,712
Flags
use code U-1287
Product numbers
002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,415,335, use patent
patent.txt lines 2,650, 2,714
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,426,399, use patent
patent.txt lines 2,651, 2,715
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,518,929, use patent
patent.txt lines 2,657, 2,720
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,524,698, use patent
patent.txt lines 2,658, 2,721
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,546,372, use patent
patent.txt lines 2,659, 2,722
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,680,144, use patent
patent.txt lines 2,669, 2,731
Flags
use code U-2695
Product numbers
001, 002
10 Feb 2030 · NDA 201444 · SODIUM NITRITE; SODIUM THIOSULFATE
US 11,753,301, substance and product and use patent
patent.txt line 2,431
Flags
substance product use code U-3681
Product numbers
001
10 Feb 2030 · NDA 201444 · SODIUM NITRITE; SODIUM THIOSULFATE
US 12,304,813, product patent
patent.txt line 2,432
Flags
product
Product numbers
001
10 Feb 2030 · NDA 201444 · SODIUM NITRITE; SODIUM THIOSULFATE
US 9,687,506, product and use patent
patent.txt line 2,437
Flags
product use code U-3394
Product numbers
001
10 Feb 2030 · NDA 201444 · SODIUM NITRITE; SODIUM THIOSULFATE
US 9,687,506, product and use patent
patent.txt line 2,438
Flags
product use code U-3395
Product numbers
001
10 Feb 2030 · NDA 203922 · SODIUM NITRITE
US 9,687,506, product and use patent
patent.txt line 4,179
Flags
product use code U-3394
Product numbers
001
10 Feb 2030 · NDA 203922 · SODIUM NITRITE
US 9,687,506, product and use patent
patent.txt line 4,180
Flags
product use code U-3395
Product numbers
001
10 Feb 2030 · NDA 203923 · SODIUM THIOSULFATE
US 11,753,301, substance and product and use patent
patent.txt line 4,182
Flags
substance product use code U-3682
Product numbers
001
10 Feb 2030 · NDA 203923 · SODIUM THIOSULFATE
US 12,304,813, product patent
patent.txt line 4,183
Flags
product
Product numbers
001
11 Feb 2030 · NDA 204629 · EMPAGLIFLOZIN
US 12,115,179, use patent
patent.txt lines 4,888, 4,919
Flags
use code U-4023
Product numbers
001, 002
11 Feb 2030 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,115,179, use patent
patent.txt lines 6,183, 6,215
Flags
use code U-4023
Product numbers
001, 002
11 Feb 2030 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,115,179, use patent
patent.txt lines 6,303, 6,334, 6,363, 6,392
Flags
use code U-4023
Product numbers
001, 002, 003, 004
11 Feb 2030 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,115,179, use patent
patent.txt lines 9,050, 9,082, 9,112, 9,142
Flags
use code U-4023
Product numbers
001, 002, 003, 004
11 Feb 2030 · NDA 211415 · CETIRIZINE HYDROCHLORIDE
US 8,513,259, use patent
patent.txt line 12,868
Flags
use code U-2636
Product numbers
001
11 Feb 2030 · NDA 211415 · CETIRIZINE HYDROCHLORIDE
US 9,119,771, use patent
patent.txt line 12,869
Flags
use code U-2635
Product numbers
001
11 Feb 2030 · NDA 211415 · CETIRIZINE HYDROCHLORIDE
US 9,180,090, use patent
patent.txt line 12,870
Flags
use code U-2635
Product numbers
001
11 Feb 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 12,115,179, use patent
patent.txt lines 14,238, 14,268, 14,298, 14,327
Flags
use code U-4023
Product numbers
001, 002, 003, 004
12 Feb 2030 · NDA 021775 · ALVIMOPAN
US 8,946,262, use patent
patent.txt line 699
Flags
use code U-1655
Product numbers
001
12 Feb 2030 · NDA 208742 · DEXAMETHASONE
US 8,563,027, use patent
patent.txt line 9,290
Flags
use code U-2487
Product numbers
001
13 Feb 2030 · NDA 203496 · TREPROSTINIL DIOLAMINE
US 8,410,169, product patent
patent.txt lines 3,949, 3,958, 3,967, 3,976, 3,985
Flags
product
Product numbers
001, 002, 003, 004, 005
23 Feb 2030 · NDA 022581 · CALCIUM ACETATE
US 8,591,938, product and use patent
patent.txt line 2,133
Flags
product use code U-1469
Product numbers
001
23 Feb 2030 · NDA 206679 · SIMVASTATIN
US 9,597,289, product patent
patent.txt lines 6,753, 6,755
Flags
product
Product numbers
001, 002
24 Feb 2030 · NDA 202428 · TAZAROTENE
US 10,568,859, product and use patent
patent.txt line 3,084
Flags
product use code U-2760
Product numbers
001
24 Feb 2030 · NDA 202428 · TAZAROTENE
US 10,688,071, product and use patent
patent.txt line 3,085
Flags
product use code U-2760
Product numbers
001
24 Feb 2030 · NDA 202428 · TAZAROTENE
US 8,808,716, product patent
patent.txt line 3,086
Flags
product
Product numbers
001
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt lines 11,504, 11,522
Flags
substance product use code U-2335
Product numbers
001, 002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,523
Flags
substance product use code U-2802
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,524
Flags
substance product use code U-2803
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,525
Flags
substance product use code U-3738
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,526
Flags
substance product use code U-4051
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,527
Flags
substance product use code U-4440
Product numbers
002
27 Feb 2030 · NDA 210496 · ENCORAFENIB
US RE49556, substance and product patent
patent.txt line 11,549
Flags
substance product
Product numbers
002
28 Feb 2030 · NDA 211415 · CETIRIZINE HYDROCHLORIDE
US 8,263,581, use patent
patent.txt line 12,866
Flags
use code U-2635
Product numbers
001
28 Feb 2030 · NDA 211415 · CETIRIZINE HYDROCHLORIDE
US 8,314,083, use patent
patent.txt line 12,867
Flags
use code U-2634
Product numbers
001
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 10,500,214, product patent
patent.txt line 6,476
Flags
product
Product numbers
001
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 8,101,593, product patent
patent.txt line 6,480
Flags
product
Product numbers
001
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 8,367,649, product patent
patent.txt line 6,482
Flags
product
Product numbers
001
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 8,653,058, product patent
patent.txt line 6,485
Flags
product
Product numbers
001
5 Mar 2030 · NDA 216956 · ETRASIMOD ARGININE
US 8,580,841, substance and product patent
patent.txt line 19,081
Flags
substance product
Product numbers
001
7 Mar 2030 · NDA 211150 · PITOLISANT HYDROCHLORIDE
US 8,207,197, substance and product patent
patent.txt lines 12,480, 12,485
Flags
substance product
Product numbers
001, 002
8 Mar 2030 · NDA 204275 · FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US 8,534,281, product patent
patent.txt lines 4,434, 4,444, 4,452
Flags
product
Product numbers
001, 002, 003
8 Mar 2030 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 8,534,281, product patent
patent.txt lines 10,409, 10,416
Flags
product
Product numbers
001, 002
10 Mar 2030 · NDA 020372 · TECHNETIUM TC-99M TETROFOSMIN KIT
US 9,549,999, product patent
patent.txt line 183
Flags
product
Product numbers
002
10 Mar 2030 · NDA 218197 · CAPIVASERTIB
US 8,101,623, substance and product and use patent
patent.txt lines 20,879, 20,889
Flags
substance product use code U-3762
Product numbers
001, 002
11 Mar 2030 · NDA 205858 · IDELALISIB
US 9,492,449, use patent
patent.txt lines 5,991, 5,995
Flags
use code U-1914
Product numbers
001, 002
12 Mar 2030 · NDA 022308 · BESIFLOXACIN HYDROCHLORIDE
US 8,604,020, product patent
patent.txt line 1,618
Flags
product
Product numbers
001
13 Mar 2030 · NDA 209410 · AMANTADINE HYDROCHLORIDE
US 8,252,331, product patent
patent.txt lines 10,349, 10,359, 10,368, 10,377
Flags
product
Product numbers
001, 002, 003, 004
15 Mar 2030 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 8,829,005, use patent
patent.txt line 9,238
Flags
use code U-1680
Product numbers
001
15 Mar 2030 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 9,750,684, product patent
patent.txt line 9,241
Flags
product
Product numbers
001
15 Mar 2030 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 9,993,471, use patent
patent.txt line 9,242
Flags
use code U-1680
Product numbers
001
16 Mar 2030 · NDA 209128 · SUFENTANIL CITRATE
US 10,896,751, product patent
patent.txt line 9,788
Flags
product
Product numbers
001
16 Mar 2030 · NDA 209128 · SUFENTANIL CITRATE
US 11,676,691, product patent
patent.txt line 9,790
Flags
product
Product numbers
001
16 Mar 2030 · NDA 209128 · SUFENTANIL CITRATE
US 12,033,733, product patent
patent.txt line 9,791
Flags
product
Product numbers
001
16 Mar 2030 · NDA 209128 · SUFENTANIL CITRATE
US 8,574,189, product patent
patent.txt line 9,798
Flags
product
Product numbers
001
17 Mar 2030 · NDA 022287 · DEXLANSOPRAZOLE
US 8,173,158, use patent
patent.txt lines 1,556, 1,570
Flags
use code U-949
Product numbers
001, 002
17 Mar 2030 · NDA 022287 · DEXLANSOPRAZOLE
US 8,173,158, use patent
patent.txt lines 1,557, 1,571
Flags
use code U-950
Product numbers
001, 002
17 Mar 2030 · NDA 022287 · DEXLANSOPRAZOLE
US 8,173,158, use patent
patent.txt lines 1,558, 1,572
Flags
use code U-951
Product numbers
001, 002
19 Mar 2030 · NDA 204824 · METHOTREXATE
US 11,497,753, product patent
patent.txt lines 5,063, 5,078, 5,093, 5,108, 5,123, 5,138, 5,153, 5,168
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
19 Mar 2030 · NDA 204824 · METHOTREXATE
US 12,357,642, product patent
patent.txt lines 5,065, 5,080, 5,095, 5,110, 5,125, 5,140, 5,155, 5,170
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
19 Mar 2030 · NDA 204824 · METHOTREXATE
US 8,480,631, product and use patent
patent.txt lines 5,067, 5,082, 5,097, 5,112, 5,127, 5,142, 5,157, 5,172
Flags
product use code U-1442
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
19 Mar 2030 · NDA 204824 · METHOTREXATE
US 8,579,865, product and use patent
patent.txt lines 5,069, 5,084, 5,099, 5,114, 5,129, 5,144, 5,159, 5,174
Flags
product use code U-1442
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
19 Mar 2030 · NDA 204824 · METHOTREXATE
US 8,945,063, product and use patent
patent.txt lines 5,071, 5,086, 5,101, 5,116, 5,131, 5,146, 5,161, 5,176
Flags
product use code U-1442
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
19 Mar 2030 · NDA 204824 · METHOTREXATE
US 9,421,333, product and use patent
patent.txt lines 5,072, 5,087, 5,102, 5,117, 5,132, 5,147, 5,162, 5,177
Flags
product use code U-1442
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
19 Mar 2030 · NDA 209863 · TESTOSTERONE ENANTHATE
US 11,497,753, product patent
patent.txt lines 10,928, 10,951, 10,974
Flags
product
Product numbers
001, 002, 003
19 Mar 2030 · NDA 214096 · TEPOTINIB HYDROCHLORIDE
US 8,580,781, substance and product patent
patent.txt line 15,528
Flags
substance product
Product numbers
001
23 Mar 2030 · NDA 216993 · QUIZARTINIB DIHYDROCHLORIDE
US 8,836,218, use patent
patent.txt lines 19,130, 19,141
Flags
use code U-3661
Product numbers
001, 002
24 Mar 2030 · NDA 208051 · NERATINIB MALEATE
US 9,211,291, use patent
patent.txt line 8,028
Flags
use code U-2043
Product numbers
001
24 Mar 2030 · NDA 208051 · NERATINIB MALEATE
US 9,211,291, use patent
patent.txt line 8,029
Flags
use code U-3097
Product numbers
001
24 Mar 2030 · NDA 208251 · CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE
US 8,932,610, product and use patent
patent.txt line 8,391
Flags
product use code U-1578
Product numbers
001
25 Mar 2030 · NDA 208712 · PACRITINIB CITRATE
US 8,980,873, substance and product and use patent
patent.txt line 9,263
Flags
substance product use code U-3331
Product numbers
001
25 Mar 2030 · NDA 208712 · PACRITINIB CITRATE
US 8,980,873, substance and product and use patent
patent.txt line 9,264
Flags
substance product use code U-3332
Product numbers
001
26 Mar 2030 · NDA 022395 · CAPSAICIN
US 8,821,920, product patent
patent.txt line 1,772
Flags
product
Product numbers
001
26 Mar 2030 · NDA 022410 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 8,475,832, product and use patent
patent.txt lines 1,800, 1,803, 1,806, 1,809
Flags
product use code U-1411
Product numbers
001, 002, 003, 004
29 Mar 2030 · NDA 022272 · OXYCODONE HYDROCHLORIDE
US 8,894,987, product patent
patent.txt lines 1,447, 1,462, 1,477, 1,492
Flags
product
Product numbers
001, 002, 003, 004
29 Mar 2030 · NDA 207202 · ARIPIPRAZOLE
US 8,847,766, product and use patent
patent.txt lines 7,075, 7,102, 7,129, 7,156, 7,183, 7,210
Flags
product use code U-2167
Product numbers
001, 002, 003, 004, 005, 006
29 Mar 2030 · NDA 216403 · SPARSENTAN
US 9,662,312, use patent
patent.txt lines 18,795, 18,800
Flags
use code U-4495
Product numbers
001, 002
29 Mar 2030 · NDA 216403 · SPARSENTAN
US 9,993,461, use patent
patent.txt lines 18,796, 18,801
Flags
use code U-3269
Product numbers
001, 002
29 Mar 2030 · NDA 216403 · SPARSENTAN
US 9,993,461, use patent
patent.txt lines 18,797, 18,802
Flags
use code U-3993
Product numbers
001, 002
29 Mar 2030 · NDA 216403 · SPARSENTAN
US 9,993,461, use patent
patent.txt lines 18,798, 18,803
Flags
use code U-4495
Product numbers
001, 002
31 Mar 2030 · NDA 212489 · OPICAPONE
US 10,071,085, product patent
patent.txt lines 14,085, 14,096
Flags
product
Product numbers
001, 002
31 Mar 2030 · NDA 212489 · OPICAPONE
US 10,583,130, use patent
patent.txt lines 14,086, 14,097
Flags
use code U-3869
Product numbers
001, 002
2 Apr 2030 · NDA 208032 · OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
US 8,580,282, product and use patent
patent.txt line 8,012
Flags
product use code U-1876
Product numbers
001
2 Apr 2030 · NDA 208032 · OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
US 9,308,191, product and use patent
patent.txt line 8,013
Flags
product use code U-1876
Product numbers
001
5 Apr 2030 · NDA 022192 · ILOPERIDONE
US 9,157,121, use patent
patent.txt lines 1,156, 1,170, 1,184, 1,198, 1,212, 1,226, 1,240
Flags
use code U-1674
Product numbers
001, 002, 003, 004, 005, 006, 007
5 Apr 2030 · NDA 220358 · MILSAPERIDONE
US 9,157,121, use patent
patent.txt lines 22,156, 22,176, 22,196, 22,216, 22,236, 22,256, 22,276
Flags
use code U-4436
Product numbers
001, 002, 003, 004, 005, 006, 007
5 Apr 2030 · NDA 220358 · MILSAPERIDONE
US 9,157,121, use patent
patent.txt lines 22,157, 22,177, 22,197, 22,217, 22,237, 22,257, 22,277
Flags
use code U-4437
Product numbers
001, 002, 003, 004, 005, 006, 007
7 Apr 2030 · NDA 022275 · TOLVAPTAN
US 10,905,694, product patent
patent.txt lines 1,543, 1,545, 1,547
Flags
product
Product numbers
001, 002, 003
7 Apr 2030 · NDA 204441 · TOLVAPTAN
US 10,905,694, product patent
patent.txt lines 4,686, 4,688, 4,690, 4,692, 4,694
Flags
product
Product numbers
001, 002, 003, 004, 005
9 Apr 2030 · NDA 205836 · BRIVARACETAM
US 10,729,653, product patent
patent.txt lines 5,975, 5,977, 5,979, 5,981, 5,983
Flags
product
Product numbers
001, 002, 003, 004, 005
10 Apr 2030 · NDA 201280 · LINAGLIPTIN
US 11,911,388, use patent
patent.txt line 2,330
Flags
use code U-3854
Product numbers
001
10 Apr 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,911,388, use patent
patent.txt lines 2,348, 2,366, 2,384
Flags
use code U-3854
Product numbers
001, 002, 003
10 Apr 2030 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,911,388, use patent
patent.txt lines 7,974, 7,993
Flags
use code U-3854
Product numbers
001, 002
10 Apr 2030 · NDA 215151 · VONOPRAZAN FUMARATE
US 7,977,488, substance patent
patent.txt lines 16,498, 16,500
Flags
substance
Product numbers
001, 002
10 Apr 2030 · NDA 215152 · AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE
US 7,977,488, substance patent
patent.txt line 16,502
Flags
substance
Product numbers
001
10 Apr 2030 · NDA 215153 · AMOXICILLIN; VONOPRAZAN FUMARATE
US 7,977,488, substance patent
patent.txt line 16,504
Flags
substance
Product numbers
001
12 Apr 2030 · NDA 206089 · TESTOSTERONE UNDECANOATE
US 10,543,219, use patent
patent.txt lines 6,237, 6,248, 6,259
Flags
use code U-2506
Product numbers
001, 002, 003
12 Apr 2030 · NDA 206089 · TESTOSTERONE UNDECANOATE
US 10,617,696, substance and product patent
patent.txt lines 6,238, 6,249, 6,260
Flags
substance product
Product numbers
001, 002, 003
12 Apr 2030 · NDA 206089 · TESTOSTERONE UNDECANOATE
US 11,179,403, use patent
patent.txt lines 6,240, 6,251, 6,262
Flags
use code U-2506
Product numbers
001, 002, 003
12 Apr 2030 · NDA 206089 · TESTOSTERONE UNDECANOATE
US 11,426,416, use patent
patent.txt lines 6,242, 6,253, 6,264
Flags
use code U-3420
Product numbers
001, 002, 003
12 Apr 2030 · NDA 206089 · TESTOSTERONE UNDECANOATE
US 8,778,916, product patent
patent.txt lines 6,247, 6,258, 6,269
Flags
product
Product numbers
001, 002, 003
13 Apr 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 10,159,681, use patent
patent.txt line 1,920
Flags
use code U-2510
Product numbers
001
13 Apr 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 10,772,897, use patent
patent.txt line 1,921
Flags
use code U-2958
Product numbers
001
13 Apr 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 9,283,233, use patent
patent.txt line 1,926
Flags
use code U-1821
Product numbers
001
13 Apr 2030 · NDA 022517 · DESMOPRESSIN ACETATE
US 9,974,826, use patent
patent.txt line 2,027
Flags
use code U-2326
Product numbers
001
13 Apr 2030 · NDA 022517 · DESMOPRESSIN ACETATE
US 9,974,826, use patent
patent.txt line 2,030
Flags
use code U-2327
Product numbers
002
15 Apr 2030 · NDA 213312 · SIROLIMUS
US 10,206,887, product patent
patent.txt line 14,875
Flags
product
Product numbers
001
17 Apr 2030 · NDA 022416 · ESLICARBAZEPINE ACETATE
US 8,372,431, product patent
patent.txt lines 1,816, 1,824, 1,832, 1,840
Flags
product
Product numbers
001, 002, 003, 004
17 Apr 2030 · NDA 022433 · TICAGRELOR
US 8,425,934, product patent
patent.txt lines 1,901, 1,906
Flags
product
Product numbers
001, 002
19 Apr 2030 · NDA 204767 · ACETAMINOPHEN
US 8,741,959, product patent
patent.txt line 4,996
Flags
product
Product numbers
001
19 Apr 2030 · NDA 213426 · CELECOXIB; TRAMADOL HYDROCHLORIDE
US 10,238,668, substance and product and use patent
patent.txt line 14,999
Flags
substance product use code U-3244
Product numbers
001
19 Apr 2030 · NDA 213426 · CELECOXIB; TRAMADOL HYDROCHLORIDE
US 10,245,276, substance and product patent
patent.txt line 15,000
Flags
substance product
Product numbers
001
19 Apr 2030 · NDA 213426 · CELECOXIB; TRAMADOL HYDROCHLORIDE
US 10,548,909, use patent
patent.txt line 15,001
Flags
use code U-3244
Product numbers
001
19 Apr 2030 · NDA 213426 · CELECOXIB; TRAMADOL HYDROCHLORIDE
US 11,478,488, use patent
patent.txt line 15,002
Flags
use code U-3244
Product numbers
001
19 Apr 2030 · NDA 213426 · CELECOXIB; TRAMADOL HYDROCHLORIDE
US 8,598,152, substance and product patent
patent.txt line 15,003
Flags
substance product
Product numbers
001
19 Apr 2030 · NDA 213426 · CELECOXIB; TRAMADOL HYDROCHLORIDE
US 9,012,440, substance and product patent
patent.txt line 15,005
Flags
substance product
Product numbers
001
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 8,679,544, product patent
patent.txt lines 4,842, 4,849
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 8,999,387, use patent
patent.txt lines 4,843, 4,850
Flags
use code U-55
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,017,721, product patent
patent.txt lines 4,844, 4,851
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,173,854, product patent
patent.txt lines 4,845, 4,852
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,180,095, use patent
patent.txt lines 4,846, 4,853
Flags
use code U-55
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,180,096, product patent
patent.txt lines 4,847, 4,854
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,186,328, use patent
patent.txt lines 4,848, 4,855
Flags
use code U-55
Product numbers
001, 002
23 Apr 2030 · NDA 204768 · INDOMETHACIN
US 8,734,847, product patent
patent.txt lines 4,997, 5,000
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204768 · INDOMETHACIN
US 8,992,982, product patent
patent.txt lines 4,998, 5,001
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204768 · INDOMETHACIN
US 9,089,471, use patent
patent.txt lines 4,999, 5,002
Flags
use code U-55
Product numbers
001, 002
26 Apr 2030 · NDA 206334 · ORITAVANCIN DIPHOSPHATE
US 9,682,061, use patent
patent.txt line 6,493
Flags
use code U-1569
Product numbers
001
26 Apr 2030 · NDA 214155 · ORITAVANCIN DIPHOSPHATE
US 9,682,061, use patent
patent.txt line 15,575
Flags
use code U-3101
Product numbers
001
27 Apr 2030 · NDA 202788 · FENTANYL
US 8,486,972, product patent
patent.txt lines 3,168, 3,178, 3,187, 3,197, 3,207, 3,216, 3,226
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
27 Apr 2030 · NDA 202788 · FENTANYL
US 8,486,973, use patent
patent.txt lines 3,169, 3,179, 3,188, 3,198, 3,208, 3,217, 3,227
Flags
use code U-55
Product numbers
001, 002, 003, 004, 005, 006, 007
27 Apr 2030 · NDA 207202 · ARIPIPRAZOLE
US 8,545,402, product patent
patent.txt lines 7,070, 7,097, 7,124, 7,151, 7,178, 7,205
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
27 Apr 2030 · NDA 207986 · CIPROFLOXACIN
US 8,318,817, use patent
patent.txt line 7,916
Flags
use code U-1792
Product numbers
001
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,010,517, use patent
patent.txt lines 2,620, 2,683
Flags
use code U-2690
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,265,287, use patent
patent.txt lines 2,621, 2,684
Flags
use code U-2700
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,792,267, use patent
patent.txt lines 2,633, 2,696
Flags
use code U-2961
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,842,766, use patent
patent.txt lines 2,635, 2,698
Flags
use code U-2997
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,881,632, use patent
patent.txt lines 2,637, 2,700
Flags
use code U-3052
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,103,477, use patent
patent.txt lines 2,640, 2,703
Flags
use code U-3209
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,154,526, use patent
patent.txt lines 2,642, 2,705
Flags
use code U-3240
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,213,504, use patent
patent.txt lines 2,643, 2,706
Flags
use code U-3292
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,717,504, use patent
patent.txt lines 2,646, 2,709
Flags
use code U-3669
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,298,554, product patent
patent.txt lines 2,648, 2,711
Flags
product
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,445,003, use patent
patent.txt lines 2,652, 2,716
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,445,013, use patent
patent.txt lines 2,653, 2,717
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,454,994, use patent
patent.txt lines 2,654, 2,718
Flags
use code U-2689
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,501,225, use patent
patent.txt lines 2,656, 2,719
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,563,608, use patent
patent.txt lines 2,660, 2,723
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,593, use patent
patent.txt line 2,661
Flags
use code U-1478
Product numbers
001
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,593, use patent
patent.txt lines 2,662, 2,725
Flags
use code U-2691
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,593, use patent
patent.txt line 2,724
Flags
use code U-1287
Product numbers
002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,594, use patent
patent.txt lines 2,663, 2,726
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,618,166, use patent
patent.txt line 2,664
Flags
use code U-2689
Product numbers
001
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,623,406, use patent
patent.txt line 2,665
Flags
use code U-1478
Product numbers
001
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,623,406, use patent
patent.txt lines 2,666, 2,728
Flags
use code U-2692
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,623,406, use patent
patent.txt line 2,727
Flags
use code U-1287
Product numbers
002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,642,077, use patent
patent.txt lines 2,667, 2,729
Flags
use code U-2693
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,691,871, use patent
patent.txt lines 2,670, 2,732
Flags
use code U-2689
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,703,185, use patent
patent.txt lines 2,671, 2,733
Flags
use code U-2691
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,709,475, use patent
patent.txt lines 2,672, 2,734
Flags
use code U-2689
Product numbers
001, 002
29 Apr 2030 · NDA 207318 · PIMAVANSERIN TARTRATE
US 7,601,740, substance and product patent
patent.txt lines 7,233, 7,242
Flags
substance product
Product numbers
001, 002
29 Apr 2030 · NDA 210793 · PIMAVANSERIN TARTRATE
US 7,601,740, substance and product patent
patent.txt line 12,147
Flags
substance product
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 10,918,635, use patent
patent.txt line 1,931
Flags
use code U-1455
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 10,918,635, use patent
patent.txt line 1,932
Flags
use code U-172
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,202,752, use patent
patent.txt line 1,933
Flags
use code U-1455
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,202,752, use patent
patent.txt line 1,934
Flags
use code U-172
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,850,245, use patent
patent.txt line 1,935
Flags
use code U-1455
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,850,245, use patent
patent.txt line 1,936
Flags
use code U-172
Product numbers
001
30 Apr 2030 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,633,219, product and use patent
patent.txt line 3,638
Flags
product use code U-257
Product numbers
001
30 Apr 2030 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,633,219, product and use patent
patent.txt line 7,355
Flags
product use code U-257
Product numbers
001
1 May 2030 · NDA 022301 · MESALAMINE
US 8,865,688, use patent
patent.txt line 1,605
Flags
use code U-1310
Product numbers
001
2 May 2030 · NDA 211801 · TENAPANOR HYDROCHLORIDE
US 9,006,281, use patent
patent.txt line 13,187
Flags
use code U-2626
Product numbers
001
12 May 2030 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 8,088,368, substance and product patent
patent.txt lines 5,915, 5,948
Flags
substance product
Product numbers
001, 002
12 May 2030 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 8,273,341, use patent
patent.txt lines 5,917, 5,950
Flags
use code U-1470
Product numbers
001, 002
12 May 2030 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 8,822,430, substance and product and use patent
patent.txt lines 5,929, 5,962
Flags
substance product use code U-1470
Product numbers
001, 002
12 May 2030 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 8,841,278, product and use patent
patent.txt lines 5,931, 5,964
Flags
product use code U-1470
Product numbers
001, 002
12 May 2030 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 9,511,056, product and use patent
patent.txt line 5,941
Flags
product use code U-1470
Product numbers
001
12 May 2030 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 9,511,056, use patent
patent.txt line 5,974
Flags
use code U-1470
Product numbers
002
12 May 2030 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 8,088,368, substance and product patent
patent.txt lines 13,988, 14,019
Flags
substance product
Product numbers
001, 002
12 May 2030 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 8,273,341, use patent
patent.txt lines 13,990, 14,021
Flags
use code U-1470
Product numbers
001, 002
12 May 2030 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 8,822,430, substance and product and use patent
patent.txt lines 14,002, 14,033
Flags
substance product use code U-1470
Product numbers
001, 002
12 May 2030 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 8,841,278, product and use patent
patent.txt lines 14,004, 14,035
Flags
product use code U-1470
Product numbers
001, 002
12 May 2030 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 9,511,056, use patent
patent.txt lines 14,014, 14,045
Flags
use code U-1470
Product numbers
001, 002
14 May 2030 · NDA 208742 · DEXAMETHASONE
US 8,409,606, product patent
patent.txt line 9,289
Flags
product
Product numbers
001
14 May 2030 · NDA 216993 · QUIZARTINIB DIHYDROCHLORIDE
US 9,555,040, use patent
patent.txt lines 19,133, 19,144
Flags
use code U-3661
Product numbers
001, 002
16 May 2030 · NDA 209388 · METOCLOPRAMIDE HYDROCHLORIDE
US 8,334,281, product and use patent
patent.txt line 10,293
Flags
product use code U-2843
Product numbers
001
19 May 2030 · NDA 204026 · POMALIDOMIDE
US 10,555,939, product patent
patent.txt lines 4,197, 4,203, 4,209, 4,215
Flags
product
Product numbers
001, 002, 003, 004
19 May 2030 · NDA 204026 · POMALIDOMIDE
US 9,993,467, product patent
patent.txt lines 4,201, 4,207, 4,213, 4,219
Flags
product
Product numbers
001, 002, 003, 004
20 May 2030 · NDA 214938 · VOSORITIDE
US RE48267, use patent
patent.txt lines 16,360, 16,368, 16,376
Flags
use code U-3927
Product numbers
001, 002, 003
21 May 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705, product patent
patent.txt lines 2,359, 2,377, 2,395
Flags
product
Product numbers
001, 002, 003
21 May 2030 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705, product patent
patent.txt lines 7,983, 8,002
Flags
product
Product numbers
001, 002
21 May 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705, product patent
patent.txt lines 14,251, 14,281, 14,311, 14,340
Flags
product
Product numbers
001, 002, 003, 004
22 May 2030 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 8,470,361, product and use patent
patent.txt lines 4,375, 4,385, 4,394, 4,403, 4,412, 4,419
Flags
product use code U-1425
Product numbers
001, 002, 003, 004, 005, 006
24 May 2030 · NDA 220142 · BRIMONIDINE TARTRATE; CARBACHOL
US 8,455,494, use patent
patent.txt line 22,102
Flags
use code U-3741
Product numbers
001
24 May 2030 · NDA 220142 · BRIMONIDINE TARTRATE; CARBACHOL
US 8,455,494, use patent
patent.txt line 22,103
Flags
use code U-4419
Product numbers
001
24 May 2030 · NDA 220142 · BRIMONIDINE TARTRATE; CARBACHOL
US 8,455,494, use patent
patent.txt line 22,104
Flags
use code U-4420
Product numbers
001
25 May 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,685,980, substance and product patent
patent.txt line 9,701
Flags
substance product
Product numbers
001
25 May 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,685,980, substance and product patent
patent.txt line 11,046
Flags
substance product
Product numbers
001
26 May 2030 · NDA 202293 · DAPAGLIFLOZIN
US 8,685,934, use patent
patent.txt lines 2,996, 3,034
Flags
use code U-1522
Product numbers
001, 002
26 May 2030 · NDA 205649 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 8,685,934, use patent
patent.txt lines 5,717, 5,727, 5,737, 5,747, 5,757
Flags
use code U-1522
Product numbers
001, 002, 003, 004, 005
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,869, 8,883, 8,897
Flags
use code U-2323
Product numbers
001, 002, 003
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,870, 8,884, 8,898
Flags
use code U-2445
Product numbers
001, 002, 003
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,871, 8,885, 8,899
Flags
use code U-2446
Product numbers
001, 002, 003
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,872, 8,886, 8,900
Flags
use code U-2537
Product numbers
001, 002, 003
26 May 2030 · NDA 210583 · MELOXICAM
US 10,709,713, use patent
patent.txt line 12,028
Flags
use code U-2750
Product numbers
001
26 May 2030 · NDA 210583 · MELOXICAM
US 11,253,478, product and use patent
patent.txt line 12,030
Flags
product use code U-3318
Product numbers
001
26 May 2030 · NDA 210583 · MELOXICAM
US 9,974,746, product patent
patent.txt line 12,032
Flags
product
Product numbers
001
28 May 2030 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 10,864,183, product patent
patent.txt line 7,056
Flags
product
Product numbers
001
28 May 2030 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 11,020,363, product patent
patent.txt line 7,058
Flags
product
Product numbers
001
28 May 2030 · NDA 208294 · FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 10,716,753, product and use patent
patent.txt line 8,442
Flags
product use code U-2889
Product numbers
001
28 May 2030 · NDA 208294 · FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,324,266, use patent
patent.txt line 8,443
Flags
use code U-2889
Product numbers
001
28 May 2030 · NDA 208294 · FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,703,806, use patent
patent.txt line 8,444
Flags
use code U-2889
Product numbers
001
28 May 2030 · NDA 208294 · FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,808,713, product and use patent
patent.txt line 8,445
Flags
product use code U-2889
Product numbers
001
28 May 2030 · NDA 208294 · FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 9,415,009, use patent
patent.txt line 8,447
Flags
use code U-2889
Product numbers
001
28 May 2030 · NDA 208294 · FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 9,463,161, product and use patent
patent.txt line 8,448
Flags
product use code U-2889
Product numbers
001
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 10,716,753, product and use patent
patent.txt line 13,581
Flags
product use code U-2889
Product numbers
001
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 10,716,753, product and use patent
patent.txt line 13,590
Flags
product use code U-4503
Product numbers
002
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,324,266, use patent
patent.txt line 13,584
Flags
use code U-2889
Product numbers
001
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,324,266, use patent
patent.txt line 13,593
Flags
use code U-4503
Product numbers
002
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,703,806, use patent
patent.txt line 13,585
Flags
use code U-2889
Product numbers
001
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,703,806, use patent
patent.txt line 13,594
Flags
use code U-4503
Product numbers
002
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,808,713, product and use patent
patent.txt line 13,586
Flags
product use code U-2889
Product numbers
001
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 8,808,713, product and use patent
patent.txt line 13,595
Flags
product use code U-4503
Product numbers
002
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 9,415,009, use patent
patent.txt line 13,588
Flags
use code U-2889
Product numbers
001
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 9,415,009, use patent
patent.txt line 13,597
Flags
use code U-4503
Product numbers
002
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 9,463,161, product and use patent
patent.txt line 13,589
Flags
product use code U-2889
Product numbers
001
28 May 2030 · NDA 212122 · BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 9,463,161, product and use patent
patent.txt line 13,598
Flags
product use code U-4503
Product numbers
002
28 May 2030 · NDA 214070 · ALBUTEROL SULFATE; BUDESONIDE
US 9,415,009, use patent
patent.txt line 15,462
Flags
use code U-3509
Product numbers
001
28 May 2030 · NDA 216579 · BUDESONIDE; FORMOTEROL FUMARATE
US 10,716,753, product and use patent
patent.txt line 18,868
Flags
product use code U-3203
Product numbers
001
28 May 2030 · NDA 216579 · BUDESONIDE; FORMOTEROL FUMARATE
US 10,716,753, product and use patent
patent.txt lines 18,869, 18,872
Flags
product use code U-4513
Product numbers
001, 002
28 May 2030 · NDA 216579 · BUDESONIDE; FORMOTEROL FUMARATE
US 9,415,009, use patent
patent.txt line 18,870
Flags
use code U-3203
Product numbers
001
28 May 2030 · NDA 216579 · BUDESONIDE; FORMOTEROL FUMARATE
US 9,415,009, use patent
patent.txt lines 18,871, 18,873
Flags
use code U-4513
Product numbers
001, 002
29 May 2030 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 8,337,824, substance and use patent
patent.txt lines 5,828, 5,835, 5,842, 5,849
Flags
substance use code U-1766
Product numbers
001, 002, 003, 004
2 Jun 2030 · NDA 022145 · RALTEGRAVIR POTASSIUM
US 8,771,733, substance and product and use patent
patent.txt lines 1,115, 1,120
Flags
substance product use code U-257
Product numbers
001, 002
2 Jun 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 8,512,745, product patent
patent.txt line 1,923
Flags
product
Product numbers
001
2 Jun 2030 · NDA 203045 · RALTEGRAVIR POTASSIUM
US 8,771,733, substance and product and use patent
patent.txt line 3,604
Flags
substance product use code U-257
Product numbers
002
2 Jun 2030 · NDA 203085 · REGORAFENIB
US 8,680,124, use patent
patent.txt line 3,606
Flags
use code U-1506
Product numbers
001
3 Jun 2030 · NDA 214120 · AZACITIDINE
US 8,846,628, product and use patent
patent.txt lines 15,552, 15,555
Flags
product use code U-2950
Product numbers
001, 002
4 Jun 2030 · NDA 201280 · LINAGLIPTIN
US 8,846,695, use patent
patent.txt line 2,337
Flags
use code U-1503 delist requested
Product numbers
001
4 Jun 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 8,846,695, use patent
patent.txt lines 2,355, 2,373
Flags
use code U-1503
Product numbers
001, 002
4 Jun 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 8,846,695, use patent
patent.txt line 2,391
Flags
use code U-1503 delist requested
Product numbers
003
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 268
Flags
use code U-2281
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 269
Flags
use code U-2890
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 270
Flags
use code U-2891
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 271
Flags
use code U-2892
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 272
Flags
use code U-2893
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 273
Flags
use code U-2894
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 274
Flags
use code U-2895
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 275
Flags
use code U-2896
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 276
Flags
use code U-2897
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 277
Flags
use code U-2898
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 278
Flags
use code U-2899
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 279
Flags
use code U-2900
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 280
Flags
use code U-2901
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 281
Flags
use code U-2902
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 282
Flags
use code U-2903
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 283
Flags
use code U-2904
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 284
Flags
use code U-2905
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 285
Flags
use code U-2906
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 286
Flags
use code U-2907
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 287
Flags
use code U-2908
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 288
Flags
use code U-2909
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 289
Flags
use code U-2910
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 290
Flags
use code U-2911
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 291
Flags
use code U-2912
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 292
Flags
use code U-2913
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 293
Flags
use code U-2914
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 294
Flags
use code U-2915
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 295
Flags
use code U-2916
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 296
Flags
use code U-2917
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 297
Flags
use code U-2918
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 298
Flags
use code U-2919
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 299
Flags
use code U-2920
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 300
Flags
use code U-2921
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 301
Flags
use code U-2922
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 302
Flags
use code U-2923
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 303
Flags
use code U-2924
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 304
Flags
use code U-2925
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 305
Flags
use code U-2926
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 306
Flags
use code U-2927
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 307
Flags
use code U-2928
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 308
Flags
use code U-2929
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 309
Flags
use code U-2930
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 310
Flags
use code U-2931
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 311
Flags
use code U-2932
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 312
Flags
use code U-2933
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 313
Flags
use code U-2934
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 314
Flags
use code U-2935
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 315
Flags
use code U-2936
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 10,688,155, use patent
patent.txt line 316
Flags
use code U-2937
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 8,877,708, product and use patent
patent.txt line 327
Flags
product use code U-1706
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 329
Flags
use code U-2111
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 330
Flags
use code U-2112
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 331
Flags
use code U-2113
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 332
Flags
use code U-2114
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 333
Flags
use code U-2115
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 334
Flags
use code U-2116
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 335
Flags
use code U-2117
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 336
Flags
use code U-2118
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,352,025, use patent
patent.txt line 337
Flags
use code U-2119
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 356
Flags
use code U-2114
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 357
Flags
use code U-2116
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 358
Flags
use code U-2281
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 359
Flags
use code U-2282
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 360
Flags
use code U-2283
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 361
Flags
use code U-2284
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 362
Flags
use code U-2285
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 363
Flags
use code U-2286
Product numbers
001
7 Jun 2030 · NDA 020866 · BROMOCRIPTINE MESYLATE
US 9,895,422, use patent
patent.txt line 364
Flags
use code U-2287
Product numbers
001
9 Jun 2030 · NDA 208434 · ALECTINIB HYDROCHLORIDE
US 9,440,922, product patent
patent.txt line 8,620
Flags
product
Product numbers
001
10 Jun 2030 · NDA 206619 · DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US 9,006,387, use patent
patent.txt line 6,611
Flags
use code U-1687
Product numbers
001
10 Jun 2030 · NDA 207931 · OMBITASVIR; PARITAPREVIR; RITONAVIR
US 9,006,387, use patent
patent.txt line 7,653
Flags
use code U-1687
Product numbers
001
10 Jun 2030 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US 9,006,387, use patent
patent.txt line 9,007
Flags
use code U-1687
Product numbers
001
10 Jun 2030 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,028,937, use patent
patent.txt line 10,295
Flags
use code U-2141
Product numbers
001
10 Jun 2030 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,028,937, use patent
patent.txt line 10,296
Flags
use code U-3237
Product numbers
001
10 Jun 2030 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,028,937, use patent
patent.txt line 10,297
Flags
use code U-4206
Product numbers
001
10 Jun 2030 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,039,754, use patent
patent.txt line 10,299
Flags
use code U-2141
Product numbers
001
10 Jun 2030 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,039,754, use patent
patent.txt line 10,300
Flags
use code U-3237
Product numbers
001
10 Jun 2030 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,039,754, use patent
patent.txt line 10,301
Flags
use code U-4206
Product numbers
001
10 Jun 2030 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 10,028,937, use patent
patent.txt line 16,477
Flags
use code U-3238
Product numbers
001
10 Jun 2030 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 10,028,937, use patent
patent.txt line 16,478
Flags
use code U-4206
Product numbers
001
10 Jun 2030 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 10,039,754, use patent
patent.txt line 16,480
Flags
use code U-3238
Product numbers
001
10 Jun 2030 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 10,039,754, use patent
patent.txt line 16,481
Flags
use code U-4206
Product numbers
001
11 Jun 2030 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 10,420,763, product and use patent
patent.txt lines 12,314, 12,326, 12,338, 12,350, 12,362
Flags
product use code U-2825
Product numbers
001, 002, 003, 004, 005
11 Jun 2030 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 9,044,475, product patent
patent.txt lines 12,321, 12,333, 12,345, 12,357, 12,369
Flags
product
Product numbers
001, 002, 003, 004, 005
11 Jun 2030 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 9,283,219, product and use patent
patent.txt lines 12,322, 12,334, 12,346, 12,358, 12,370
Flags
product use code U-2825
Product numbers
001, 002, 003, 004, 005
11 Jun 2030 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 9,326,981, use patent
patent.txt lines 12,323, 12,335, 12,347, 12,359, 12,371
Flags
use code U-2825
Product numbers
001, 002, 003, 004, 005
11 Jun 2030 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 9,669,019, product and use patent
patent.txt lines 12,324, 12,336, 12,348, 12,360, 12,372
Flags
product use code U-2825
Product numbers
001, 002, 003, 004, 005
11 Jun 2030 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 9,669,021, use patent
patent.txt lines 12,325, 12,337, 12,349, 12,361, 12,373
Flags
use code U-2825
Product numbers
001, 002, 003, 004, 005
11 Jun 2030 · NDA 214324 · TREPROSTINIL
US 10,772,883, product patent
patent.txt lines 15,676, 15,684, 15,692, 15,700, 15,708
Flags
product
Product numbers
001, 002, 003, 004, 005
12 Jun 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 8,426,392, use patent
patent.txt line 1,922
Flags
use code U-1389
Product numbers
001
12 Jun 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 8,962,603, use patent
patent.txt line 1,925
Flags
use code U-1657
Product numbers
001
14 Jun 2030 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 10,940,128, product and use patent
patent.txt line 7,057
Flags
product use code U-3086
Product numbers
001
14 Jun 2030 · NDA 210854 · BALOXAVIR MARBOXIL
US 9,815,835, product patent
patent.txt lines 12,192, 12,203, 12,214
Flags
product
Product numbers
001, 002, 003
14 Jun 2030 · NDA 214410 · BALOXAVIR MARBOXIL
US 9,815,835, product patent
patent.txt lines 15,764, 15,775, 15,786
Flags
product
Product numbers
001, 002, 003
15 Jun 2030 · NDA 201656 · DESMOPRESSIN ACETATE
US 11,419,914, use patent
patent.txt lines 2,542, 2,545
Flags
use code U-3431
Product numbers
001, 002
15 Jun 2030 · NDA 201656 · DESMOPRESSIN ACETATE
US 12,090,190, product and use patent
patent.txt lines 2,543, 2,546
Flags
product use code U-4003
Product numbers
001, 002
15 Jun 2030 · NDA 201656 · DESMOPRESSIN ACETATE
US 9,539,302, product patent
patent.txt lines 2,544, 2,547
Flags
product
Product numbers
001, 002
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,842,768, use patent
patent.txt lines 2,636, 2,699
Flags
use code U-2688
Product numbers
001, 002
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,410,086, use patent
patent.txt lines 2,649, 2,713
Flags
use code U-2688
Product numbers
001, 002
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,455,472, use patent
patent.txt line 2,655
Flags
use code U-2690
Product numbers
001
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,669,245, use patent
patent.txt lines 2,668, 2,730
Flags
use code U-2694
Product numbers
001, 002
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,710,041, use patent
patent.txt lines 2,673, 2,735
Flags
use code U-2690
Product numbers
001, 002
15 Jun 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 10,406,172, product and use patent
patent.txt lines 14,228, 14,258, 14,288, 14,318
Flags
product use code U-2733
Product numbers
001, 002, 003, 004
16 Jun 2030 · NDA 203791 · ACYCLOVIR
US 8,592,434, product and use patent
patent.txt line 4,157
Flags
product use code U-1460
Product numbers
001
16 Jun 2030 · NDA 210884 · SUMATRIPTAN
US 10,603,305, product and use patent
patent.txt line 12,374
Flags
product use code U-1719
Product numbers
001
16 Jun 2030 · NDA 210884 · SUMATRIPTAN
US 11,337,962, product and use patent
patent.txt line 12,375
Flags
product use code U-1719
Product numbers
001
16 Jun 2030 · NDA 210884 · SUMATRIPTAN
US 12,090,139, product patent
patent.txt line 12,376
Flags
product
Product numbers
001
16 Jun 2030 · NDA 210884 · SUMATRIPTAN
US 9,610,280, product and use patent
patent.txt line 12,381
Flags
product use code U-1719
Product numbers
001
16 Jun 2030 · NDA 210884 · SUMATRIPTAN
US 9,974,770, product and use patent
patent.txt line 12,382
Flags
product use code U-1719
Product numbers
001
17 Jun 2030 · NDA 204251 · BRIMONIDINE TARTRATE; BRINZOLAMIDE
US 9,421,265, product patent
patent.txt line 4,424
Flags
product
Product numbers
001
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,620, 10,628, 10,635
Flags
use code U-1942
Product numbers
001, 002, 003
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,621, 10,629, 10,636
Flags
use code U-1943
Product numbers
001, 002, 003
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,622, 10,630, 10,637
Flags
use code U-2093
Product numbers
001, 002, 003
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,623, 10,631, 10,638
Flags
use code U-2094
Product numbers
001, 002, 003
18 Jun 2030 · NDA 218010 · TRAVOPROST
US 12,201,557, substance and product and use patent
patent.txt line 20,783
Flags
substance product use code U-4129
Product numbers
001
20 Jun 2030 · NDA 219491 · ZOLIFLODACIN
US 8,658,641, substance patent
patent.txt line 21,783
Flags
substance
Product numbers
001
21 Jun 2030 · NDA 202860 · NITRIC OXIDE
US 11,103,669, product patent
patent.txt line 3,411
Flags
product
Product numbers
001
21 Jun 2030 · NDA 207202 · ARIPIPRAZOLE
US 8,114,021, product patent
patent.txt lines 7,068, 7,095, 7,122, 7,149, 7,176, 7,203
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
21 Jun 2030 · NDA 209606 · ENASIDENIB MESYLATE
US 10,610,125, use patent
patent.txt lines 10,664, 10,670
Flags
use code U-2087
Product numbers
001, 002
21 Jun 2030 · NDA 211192 · IVOSIDENIB
US 10,610,125, use patent
patent.txt line 12,511
Flags
use code U-2784
Product numbers
001
21 Jun 2030 · NDA 211192 · IVOSIDENIB
US 10,610,125, use patent
patent.txt line 12,512
Flags
use code U-2785
Product numbers
001
21 Jun 2030 · NDA 211192 · IVOSIDENIB
US 10,610,125, use patent
patent.txt line 12,513
Flags
use code U-3385
Product numbers
001
24 Jun 2030 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 10,112,903, substance and use patent
patent.txt lines 7,274, 7,291, 7,309, 7,327
Flags
substance use code U-543
Product numbers
001, 002, 003, 004
24 Jun 2030 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 8,796,276, use patent
patent.txt lines 7,287, 7,304, 7,322, 7,340
Flags
use code U-543
Product numbers
001, 002, 003, 004
24 Jun 2030 · NDA 209830 · ARIPIPRAZOLE LAUROXIL
US 10,112,903, substance and use patent
patent.txt line 10,887
Flags
substance use code U-543
Product numbers
001
24 Jun 2030 · NDA 209830 · ARIPIPRAZOLE LAUROXIL
US 8,796,276, use patent
patent.txt line 10,894
Flags
use code U-543
Product numbers
001
25 Jun 2030 · NDA 207947 · SELEXIPAG
US 9,284,280, use patent
patent.txt lines 7,705, 7,717, 7,729, 7,741, 7,753, 7,765, 7,777, 7,789, 7,801, 7,813
Flags
use code U-1831
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 010, 011
25 Jun 2030 · NDA 214275 · SELEXIPAG
US 9,284,280, use patent
patent.txt line 15,665
Flags
use code U-1831
Product numbers
001
27 Jun 2030 · NDA 022388 · KETOTIFEN FUMARATE
US 9,962,376, product patent
patent.txt line 1,771
Flags
product
Product numbers
001
28 Jun 2030 · NDA 219683 · GEMCITABINE HYDROCHLORIDE
US 12,403,086, product patent
patent.txt line 21,859
Flags
product
Product numbers
001
29 Jun 2030 · NDA 205755 · CERITINIB
US 8,039,479, substance and product patent
patent.txt line 5,854
Flags
substance product
Product numbers
001
29 Jun 2030 · NDA 211225 · CERITINIB
US 8,039,479, substance and product patent
patent.txt line 12,550
Flags
substance product
Product numbers
001

Pediatric exclusivity, as listed (56)

2 Jan 2030 · NDA 206038 · IVACAFTOR; LUMACAFTOR
US 8,846,718 with pediatric exclusivity, as listed
patent.txt lines 6,114, 6,159
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
2 Jan 2030 · NDA 211358 · IVACAFTOR; LUMACAFTOR
US 8,846,718 with pediatric exclusivity, as listed
patent.txt lines 12,743, 12,785, 12,827
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
16 Jan 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US RE47350 with pediatric exclusivity, as listed
patent.txt lines 4,558, 4,629, 4,646
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 005, 006
16 Jan 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US RE49110 with pediatric exclusivity, as listed
patent.txt lines 4,564, 4,582, 4,598, 4,613, 4,634, 4,651
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006
16 Jan 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US RE49302 with pediatric exclusivity, as listed
patent.txt lines 4,569, 4,587, 4,602, 4,617
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
5 Feb 2030 · NDA 201280 · LINAGLIPTIN
US 10,034,877 with pediatric exclusivity, as listed
patent.txt line 2,326
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
5 Feb 2030 · NDA 201280 · LINAGLIPTIN
US 9,486,526 with pediatric exclusivity, as listed
patent.txt line 2,342
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
12 Feb 2030 · NDA 207947 · SELEXIPAG
US 9,173,881 with pediatric exclusivity, as listed
patent.txt lines 7,702, 7,714, 7,726, 7,738, 7,750, 7,762, 7,774, 7,786, 7,798, 7,810
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 010, 011
12 Feb 2030 · NDA 214275 · SELEXIPAG
US 9,173,881 with pediatric exclusivity, as listed
patent.txt line 15,662
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 203188 · IVACAFTOR
US 10,646,481 with pediatric exclusivity, as listed
patent.txt line 3,651
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 203188 · IVACAFTOR
US 11,564,916 with pediatric exclusivity, as listed
patent.txt line 3,653
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 203188 · IVACAFTOR
US 12,458,635 with pediatric exclusivity, as listed
patent.txt line 3,655
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 206038 · IVACAFTOR; LUMACAFTOR
US 10,646,481 with pediatric exclusivity, as listed
patent.txt lines 6,083, 6,131
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
13 Feb 2030 · NDA 206038 · IVACAFTOR; LUMACAFTOR
US 11,564,916 with pediatric exclusivity, as listed
patent.txt lines 6,087, 6,135
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
13 Feb 2030 · NDA 206038 · IVACAFTOR; LUMACAFTOR
US 12,458,635 with pediatric exclusivity, as listed
patent.txt lines 6,091, 6,139
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
13 Feb 2030 · NDA 207925 · IVACAFTOR
US 10,646,481 with pediatric exclusivity, as listed
patent.txt lines 7,493, 7,526, 7,559, 7,592, 7,620
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
13 Feb 2030 · NDA 207925 · IVACAFTOR
US 11,564,916 with pediatric exclusivity, as listed
patent.txt lines 7,497, 7,530, 7,563, 7,596, 7,624
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
13 Feb 2030 · NDA 207925 · IVACAFTOR
US 12,458,635 with pediatric exclusivity, as listed
patent.txt lines 7,503, 7,536, 7,569, 7,602, 7,630
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
13 Feb 2030 · NDA 211358 · IVACAFTOR; LUMACAFTOR
US 10,646,481 with pediatric exclusivity, as listed
patent.txt lines 12,717, 12,759, 12,801
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
13 Feb 2030 · NDA 211358 · IVACAFTOR; LUMACAFTOR
US 11,564,916 with pediatric exclusivity, as listed
patent.txt lines 12,719, 12,761, 12,803
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
13 Feb 2030 · NDA 211358 · IVACAFTOR; LUMACAFTOR
US 12,458,635 with pediatric exclusivity, as listed
patent.txt lines 12,723, 12,765, 12,807
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
20 Feb 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,416,136 with pediatric exclusivity, as listed
patent.txt line 9,712
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
20 Feb 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,416,136 with pediatric exclusivity, as listed
patent.txt line 11,053
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 203094 · COBICISTAT
US 8,148,374 with pediatric exclusivity, as listed
patent.txt lines 3,623, 3,627
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Mar 2030 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,148,374 with pediatric exclusivity, as listed
patent.txt line 3,635
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 9,891,239 with pediatric exclusivity, as listed
patent.txt line 3,641
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,148,374 with pediatric exclusivity, as listed
patent.txt line 7,352
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,891,239 with pediatric exclusivity, as listed
patent.txt line 7,362
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
6 Mar 2030 · NDA 214787 · REMDESIVIR
US 8,008,264 with pediatric exclusivity, as listed
patent.txt lines 16,150, 16,182
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
17 Mar 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US 7,737,142 with pediatric exclusivity, as listed
patent.txt lines 4,550, 4,574, 4,592, 4,607, 4,622, 4,639
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006
23 Mar 2030 · NDA 022249 · BENDAMUSTINE HYDROCHLORIDE
US 8,344,006 with pediatric exclusivity, as listed
patent.txt lines 1,395, 1,401
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
003, 004
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 10,842,780 with pediatric exclusivity, as listed
patent.txt lines 3,110, 3,123
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 11,707,451 with pediatric exclusivity, as listed
patent.txt lines 3,113, 3,126
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 12,059,409 with pediatric exclusivity, as listed
patent.txt lines 3,116, 3,129
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 12,097,189 with pediatric exclusivity, as listed
patent.txt lines 3,118, 3,131
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
29 Mar 2030 · NDA 206038 · IVACAFTOR; LUMACAFTOR
US 9,192,606 with pediatric exclusivity, as listed
patent.txt lines 6,121, 6,165
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
29 Mar 2030 · NDA 211358 · IVACAFTOR; LUMACAFTOR
US 9,192,606 with pediatric exclusivity, as listed
patent.txt lines 12,749, 12,791, 12,833
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
10 Apr 2030 · NDA 201292 · AFATINIB DIMALEATE
US 8,426,586 with pediatric exclusivity, as listed
patent.txt lines 2,400, 2,410, 2,420
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
14 Apr 2030 · NDA 204629 · EMPAGLIFLOZIN
US 8,551,957 with pediatric exclusivity, as listed
patent.txt lines 4,903, 4,934
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Apr 2030 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 8,551,957 with pediatric exclusivity, as listed
patent.txt lines 6,197, 6,229
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Apr 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 8,551,957 with pediatric exclusivity, as listed
patent.txt lines 14,247, 14,277, 14,307, 14,336
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
21 Apr 2030 · NDA 202714 · CARFILZOMIB
US RE47954 with pediatric exclusivity, as listed
patent.txt lines 3,144, 3,154, 3,164
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
10 May 2030 · NDA 206192 · COBIMETINIB FUMARATE
US 7,803,839 with pediatric exclusivity, as listed
patent.txt line 6,440
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 204790 · DOLUTEGRAVIR SODIUM
US 9,242,986 with pediatric exclusivity, as listed
patent.txt lines 5,005, 5,009, 5,013
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
8 Jun 2030 · NDA 205551 · ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 5,465
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 210192 · DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 11,208
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 211994 · DOLUTEGRAVIR SODIUM; LAMIVUDINE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 13,378
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 213983 · DOLUTEGRAVIR SODIUM
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 15,420
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 215413 · ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 16,887
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
9 Jun 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,962,630 with pediatric exclusivity, as listed
patent.txt line 9,702
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
9 Jun 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,962,630 with pediatric exclusivity, as listed
patent.txt line 11,047
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
16 Jun 2030 · NDA 202293 · DAPAGLIFLOZIN
US 7,919,598 with pediatric exclusivity, as listed
patent.txt lines 2,982, 3,020
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 Jun 2030 · NDA 205649 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 7,919,598 with pediatric exclusivity, as listed
patent.txt lines 5,712, 5,722, 5,732, 5,742, 5,752
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
16 Jun 2030 · NDA 209091 · DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
US 7,919,598 with pediatric exclusivity, as listed
patent.txt lines 9,659, 9,675
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 Jun 2030 · NDA 210874 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US 7,919,598 with pediatric exclusivity, as listed
patent.txt lines 12,276, 12,286, 12,296, 12,306
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
19 Jun 2030 · NDA 201292 · AFATINIB DIMALEATE
US 8,545,884 with pediatric exclusivity, as listed
patent.txt lines 2,402, 2,412, 2,422
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003

Non-patent exclusivity (48)

1 Jan 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
PED exclusivity
exclusivity.txt line 762
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
1 Jan 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
PED exclusivity
exclusivity.txt line 816
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
19 Jan 2030 · NDA 213217 · ZANUBRUTINIB
ODE-274 exclusivity
exclusivity.txt line 1,163
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
19 Jan 2030 · NDA 213411 · TUCATINIB
ODE-422 exclusivity
exclusivity.txt lines 1,220, 1,223
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
19 Jan 2030 · NDA 218785 · ZANUBRUTINIB
ODE* exclusivity
exclusivity.txt line 2,198
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
21 Jan 2030 · NDA 214759 · TREOSULFAN
NCE exclusivity
exclusivity.txt lines 1,382, 1,385
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001, 002
23 Jan 2030 · NDA 205598 · MACIMORELIN ACETATE
PED exclusivity
exclusivity.txt line 513
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
27 Jan 2030 · NDA 216059 · PIRTOBRUTINIB
ODE-424 exclusivity
exclusivity.txt lines 1,715, 1,720
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
30 Jan 2030 · NDA 219209 · SUZETRIGINE
NCE exclusivity
exclusivity.txt line 2,263
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001
31 Jan 2030 · NDA 021845 · SILDENAFIL CITRATE
ODE-469 exclusivity
exclusivity.txt line 132
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
11 Feb 2030 · NDA 219379 · MIRDAMETINIB
NCE exclusivity
exclusivity.txt lines 2,272, 2,274, 2,276
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001, 002, 003
11 Feb 2030 · NDA 219389 · MIRDAMETINIB
NCE exclusivity
exclusivity.txt lines 2,278, 2,280
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001, 002
14 Feb 2030 · NDA 219304 · VIMSELTINIB
NCE exclusivity
exclusivity.txt lines 2,269–2,271
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001, 002, 003
17 Feb 2030 · NDA 216403 · SPARSENTAN
ODE-389 exclusivity
exclusivity.txt lines 1,755, 1,759
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
24 Feb 2030 · NDA 205552 · IBRUTINIB
PED exclusivity
exclusivity.txt lines 505, 509
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002
24 Feb 2030 · NDA 210563 · IBRUTINIB
PED exclusivity
exclusivity.txt lines 892, 896, 900, 904
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004
24 Feb 2030 · NDA 217003 · IBRUTINIB
PED exclusivity
exclusivity.txt line 1,834
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
25 Feb 2030 · NDA 213983 · DOLUTEGRAVIR SODIUM
PED exclusivity
exclusivity.txt line 1,287
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
28 Feb 2030 · NDA 216718 · OMAVELOXOLONE
ODE-427 exclusivity
exclusivity.txt line 1,786
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
2 Mar 2030 · NDA 211358 · IVACAFTOR; LUMACAFTOR
PED exclusivity
exclusivity.txt lines 955, 959, 963
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
10 Mar 2030 · NDA 217026 · TROFINETIDE
ODE-425 exclusivity
exclusivity.txt line 1,836
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
10 Mar 2030 · NDA 219884 · TROFINETIDE
ODE* exclusivity
exclusivity.txt lines 2,343, 2,347, 2,351
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
13 Mar 2030 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE-429 exclusivity
exclusivity.txt line 1,351
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
13 Mar 2030 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE* exclusivity
exclusivity.txt line 1,354
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
002
16 Mar 2030 · NDA 202806 · DABRAFENIB MESYLATE
ODE-428 exclusivity
exclusivity.txt lines 287, 291
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
16 Mar 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
ODE-428 exclusivity
exclusivity.txt lines 369, 373, 377
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
16 Mar 2030 · NDA 217513 · TRAMETINIB DIMETHYL SULFOXIDE
ODE-428 exclusivity
exclusivity.txt line 1,884
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
16 Mar 2030 · NDA 217514 · DABRAFENIB MESYLATE
ODE-428 exclusivity
exclusivity.txt line 1,888
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
21 Mar 2030 · NDA 213246 · SELPERCATINIB
PED exclusivity
exclusivity.txt lines 1,180–1,181, 1,202–1,203
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002
21 Mar 2030 · NDA 218160 · SELPERCATINIB
PED exclusivity
exclusivity.txt lines 2,049–2,050, 2,069–2,070, 2,089–2,090, 2,109–2,110
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004
22 Mar 2030 · NDA 217417 · REZAFUNGIN ACETATE
ODE-426 exclusivity
exclusivity.txt line 1,876
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
24 Mar 2030 · NDA 217759 · LENIOLISIB PHOSPHATE
ODE-430 exclusivity
exclusivity.txt line 1,930
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
24 Mar 2030 · NDA 217759 · LENIOLISIB PHOSPHATE
ODE* exclusivity
exclusivity.txt lines 1,933, 1,936
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
002, 003
25 Mar 2030 · NDA 218230 · GEPOTIDACIN MESYLATE
NCE exclusivity
exclusivity.txt line 2,134
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001
28 Mar 2030 · NDA 219019 · FITUSIRAN SODIUM
NCE exclusivity
exclusivity.txt lines 2,230, 2,233
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001, 002
2 Apr 2030 · NDA 219208 · ATRASENTAN HYDROCHLORIDE
NCE exclusivity
exclusivity.txt line 2,262
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001
25 Apr 2030 · NDA 215887 · TOFERSEN
ODE-432 exclusivity
exclusivity.txt line 1,668
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
26 Apr 2030 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
ODE-433 exclusivity
exclusivity.txt lines 1,902, 1,906
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
1 May 2030 · NDA 214755 · SODIUM OXYBATE
ODE-431 exclusivity
exclusivity.txt lines 1,371, 1,374, 1,377, 1,380
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004
3 May 2030 · NDA 207925 · IVACAFTOR
ODE-435 exclusivity
exclusivity.txt lines 646, 652
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
004, 005
8 May 2030 · NDA 219616 · AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE
NCE exclusivity
exclusivity.txt line 2,301
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001
22 May 2030 · NDA 212608 · AVAPRITINIB
ODE-434 exclusivity
exclusivity.txt lines 1,089, 1,092, 1,095, 1,099, 1,102
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004, 005
28 May 2030 · NDA 217370 · ACOLTREMON
NCE exclusivity
exclusivity.txt line 1,869
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001
5 Jun 2030 · NDA 209939 · LETERMOVIR
ODE-423 exclusivity
exclusivity.txt lines 821, 827
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
5 Jun 2030 · NDA 209940 · LETERMOVIR
ODE-423 exclusivity
exclusivity.txt lines 833, 839
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
5 Jun 2030 · NDA 219104 · LETERMOVIR
ODE* exclusivity
exclusivity.txt lines 2,246, 2,250
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
11 Jun 2030 · NDA 219713 · TALETRECTINIB ADIPATE
NCE exclusivity
exclusivity.txt line 2,320
Definition
New chemical entity (to be checked against FDA's list)
Product numbers
001
13 Jun 2030 · NDA 215498 · ODEVIXIBAT
ODE-436 exclusivity
exclusivity.txt lines 1,571, 1,575, 1,579, 1,583
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004